top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights
Search

UCB to Acquire Candid Therapeutics in Immunology Expansion Deal

  • 2 days ago
  • 1 min read

Brussels, Belgium, May 3, 2026 (UCB) -- UCB has announced plans to acquire Candid Therapeutics to strengthen its immunology pipeline. The transaction will add novel T-cell engager therapies aimed at addressing complex immune-mediated diseases. The deal is intended to broaden UCB’s research capabilities and support development of next-generation biologic treatments.


Read full article here.

 
 
 

Recent Posts

See All
Coloplast Appoints Gavin Wood as New CEO

Humlebaek, Denmark, March 4, 2026 (Coloplast) -- Coloplast has appointed Gavin Wood as its new chief executive officer. The leadership transition is aimed at supporting the company’s long-term strat

 
 
 
Teleflex Names Jason Weidman as President and CEO

Wayne, PA, April 30,2026 (Business Wire) -- Teleflex has appointed Jason Weidman as its new president and chief executive officer. The leadership transition is intended to guide the company’s strate

 
 
 

Comments

Life Science Headlines
bottom of page